The asthma mortality rate for females in Canada is forecasted to remain constant at 700 deaths per hundred women from 2024 to 2028, as indicated by a standardized rate value. There is no variation in the forecasted data from 2023, suggesting either stability in factors influencing asthma mortality or possible limitations in data accuracy. During this period, the compound annual growth rate (CAGR) remains zero due to the consistent value.

Future trends to watch for:

Advances in asthma treatment and healthcare access could potentially lower mortality rates.
Environmental changes impacting air quality might influence future asthma trends.
The emergence of new health policies regarding respiratory conditions could reshape asthma management strategies.